MX336694B - Celula geneticamente modificada y proceso para el uso de esta celula. - Google Patents

Celula geneticamente modificada y proceso para el uso de esta celula.

Info

Publication number
MX336694B
MX336694B MX2013010226A MX2013010226A MX336694B MX 336694 B MX336694 B MX 336694B MX 2013010226 A MX2013010226 A MX 2013010226A MX 2013010226 A MX2013010226 A MX 2013010226A MX 336694 B MX336694 B MX 336694B
Authority
MX
Mexico
Prior art keywords
cell
genetically modified
biotransformation
relates
present
Prior art date
Application number
MX2013010226A
Other languages
English (en)
Other versions
MX2013010226A (es
Inventor
Nick Johannes Petrus Wierckx
Tom Daniël Elink Schuurman
Sipko Maarten Kuijper
Harald Johan Ruijssenaars
Original Assignee
Purac Biochem Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purac Biochem Bv filed Critical Purac Biochem Bv
Publication of MX2013010226A publication Critical patent/MX2013010226A/es
Publication of MX336694B publication Critical patent/MX336694B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/01—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invención se refiere a célula genéticamente modificada, que comprende: (i) una primera secuencia de polinucleótido que codifica para un primer polipéptido que tiene capacidades de transporte de ácido 5-(hidroximetil) furan-2-carboxílico (HMF-ácido), que comprende una secuencia de aminoácidos que tiene al menos 45%, de manera preferente al menos 60%, tal como al menos 70%, de manera más preferente al menos 80%, tal como 90%, de manera mucho más preferente al menos 95% de similitud de secuencia con una secuencia de aminoácidos expuesta en SEQ ID NO: 1, 2, 3 ó 4;y (ii) una segunda secuencia de polinucleótido que condifica para un segundo polipéptido que tiene actividad convertidora de HMF-ácido; caracterizada porque la célula se modifica genéticamente por introducción funcional de al menos la primero secuencia de polinucleótido, y de manera preferente por introducción funcional tanto d ela primero como de la segunda secuencia de polinucleótido.
MX2013010226A 2011-03-08 2012-03-07 Celula geneticamente modificada y proceso para el uso de esta celula. MX336694B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL2006359A NL2006359C2 (en) 2011-03-08 2011-03-08 Genetically modified cell and process for use of said cell.
PCT/NL2012/050141 WO2012064195A2 (en) 2011-03-08 2012-03-07 Genetically modified cell and process for use of said cell

Publications (2)

Publication Number Publication Date
MX2013010226A MX2013010226A (es) 2014-01-08
MX336694B true MX336694B (es) 2016-01-27

Family

ID=45873204

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013010226A MX336694B (es) 2011-03-08 2012-03-07 Celula geneticamente modificada y proceso para el uso de esta celula.

Country Status (19)

Country Link
US (3) US9309546B2 (es)
EP (1) EP2683815B1 (es)
JP (2) JP6017463B2 (es)
KR (1) KR101947202B1 (es)
CN (1) CN103502441B (es)
AU (1) AU2012202889B2 (es)
BR (1) BR112013022915B1 (es)
CA (1) CA2829078C (es)
DK (1) DK2683815T3 (es)
EA (1) EA023764B9 (es)
ES (1) ES2543568T3 (es)
HU (1) HUE027066T2 (es)
MX (1) MX336694B (es)
MY (1) MY161455A (es)
NL (1) NL2006359C2 (es)
PL (1) PL2683815T3 (es)
PT (1) PT2683815E (es)
SI (1) SI2683815T1 (es)
WO (1) WO2012064195A2 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2006359C2 (en) * 2011-03-08 2012-04-24 Bird Engineering B V Genetically modified cell and process for use of said cell.
US20150152452A1 (en) * 2012-07-20 2015-06-04 Novozymes A/S Enzymatic Oxidation of 5-Hydroxymethylfurfural and Derivatives Thereof
US9528133B2 (en) 2012-09-21 2016-12-27 Synthetic Genomics, Inc. Compositions and methods for producing chemicals and derivatives thereof
CN104769122B (zh) 2012-09-21 2018-08-10 合成基因组股份有限公司 用于生产化学品和其衍生物的组合物和方法
WO2014081973A1 (en) 2012-11-21 2014-05-30 The Regents Of The University Of California Nucleic acids useful for integrating into and gene expression in hyperthermophilic acidophilic archaea
NL2011027C2 (en) 2013-06-24 2014-12-29 Univ Delft Tech Process for the preparation of 2,5-furandicarboxylic acid.
CN104371955B (zh) * 2014-10-30 2017-02-08 江南大学 一种合成2,5‑呋喃二甲酸的土生拉乌尔菌及其应用
EP3259349B1 (en) * 2015-02-17 2020-06-17 Purac Biochem B.V. Dehydrogenase-catalysed production of fdca
WO2017050815A1 (en) 2015-09-21 2017-03-30 Purac Biochem B.V. Fungal production of fdca
JP7071283B2 (ja) * 2016-12-20 2022-05-18 株式会社カネカ ポリヒドロキシアルカン酸の製造方法及び微生物
EP3366681A1 (en) 2017-02-28 2018-08-29 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO Production of 2,5-furandicarboxylic acid
EP3378931A1 (en) * 2017-03-21 2018-09-26 Purac Biochem B.V. Fdca-decarboxylating monooxygenase-deficient host cells for producing fdca
CN109609397A (zh) * 2017-10-31 2019-04-12 天津科技大学 一种水产养殖用复合微生物菌剂及应用
WO2019094740A1 (en) 2017-11-10 2019-05-16 Shell Oil Company Methods of producing 2,5-furandicarboxylic acid
EP3732174B1 (en) 2017-12-29 2023-12-27 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk Onderzoek TNO Method for purifying and removing colour of 2,5-furandicarboxylic acid (fdca)
EP3505514A1 (en) 2017-12-29 2019-07-03 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO Method for purifying and removing color of 2,5-furandicarboxylic acid (fdca)
US11339414B2 (en) * 2019-03-01 2022-05-24 Braskem S.A. Method for the in vivo synthesis of 4-hydroxymethylfurfural and derivatives thereof
CN110591995A (zh) * 2019-09-12 2019-12-20 华南理工大学 一种共表达重组菌及其在合成呋喃羧酸中的应用
CN110724654B (zh) * 2019-11-22 2020-09-29 南京科技职业学院 一株生产5-羟甲基-2呋喃甲酸的铜绿假单胞菌及其应用
TWI735113B (zh) * 2019-12-23 2021-08-01 國立清華大學 ２,５-呋喃二甲酸之製備方法
NL2024726B1 (en) 2020-01-22 2021-09-09 Biomosae B V Enzymatic crop protection and process for preparing biological crop protection composition
US20240011990A1 (en) 2020-07-17 2024-01-11 Trustees Of Boston University Viral detection systems and uses thereof
US20240115607A1 (en) 2021-01-26 2024-04-11 Cytocares (Shanghai) Inc. Chimeric antigen receptor (car) constructs and nk cells expressing car constructs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2295534A1 (en) * 2009-09-02 2011-03-16 Shell Internationale Research Maatschappij B.V. Novel microorganism and its use in lignocellulose detoxification
IN2012DN01652A (es) * 2009-09-02 2015-06-05 Dsm Ip Assets Bv
NL2006359C2 (en) * 2011-03-08 2012-04-24 Bird Engineering B V Genetically modified cell and process for use of said cell.

Also Published As

Publication number Publication date
BR112013022915A2 (pt) 2016-12-06
EP2683815B1 (en) 2015-05-20
HUE027066T2 (en) 2016-08-29
EP2683815A2 (en) 2014-01-15
US10023890B2 (en) 2018-07-17
ES2543568T3 (es) 2015-08-20
WO2012064195A2 (en) 2012-05-18
JP2017060471A (ja) 2017-03-30
AU2012202889B2 (en) 2016-09-15
PL2683815T3 (pl) 2015-10-30
WO2012064195A3 (en) 2012-08-23
BR112013022915B1 (pt) 2021-08-31
KR101947202B1 (ko) 2019-02-12
DK2683815T3 (en) 2015-07-20
US20180023105A1 (en) 2018-01-25
MX2013010226A (es) 2014-01-08
EA023764B9 (ru) 2016-10-31
US9309546B2 (en) 2016-04-12
NL2006359C2 (en) 2012-04-24
SI2683815T1 (sl) 2015-09-30
US9828616B2 (en) 2017-11-28
AU2012202889A1 (en) 2013-09-26
CN103502441B (zh) 2016-09-14
US20160257978A1 (en) 2016-09-08
KR20140015439A (ko) 2014-02-06
EA201300999A1 (ru) 2014-02-28
US20140073019A1 (en) 2014-03-13
CA2829078C (en) 2021-12-28
MY161455A (en) 2017-04-14
CA2829078A1 (en) 2012-05-18
JP6327724B2 (ja) 2018-05-23
PT2683815E (pt) 2015-09-18
JP2014508531A (ja) 2014-04-10
JP6017463B2 (ja) 2016-11-02
EA023764B1 (ru) 2016-07-29
CN103502441A (zh) 2014-01-08

Similar Documents

Publication Publication Date Title
MY161455A (en) Genetically modified cell and process for use of said cell
MX2019004568A (es) Produccion mejorada de derivados de acidos grasos.
WO2013076144A3 (en) Microorganism strains for the production of 2,3-butanediol
GEP20176628B (en) Targeted genomic alteration
WO2012112730A3 (en) Compositions and methods for delivering nucleic acid to a cell
MX2020009460A (es) Disminuir nivel de lactato e incrementar produccion de polipeptidos por regulacion a la baja de la expresion de lactato dehidrogenasa y piruvato dehidrogenasa quinasa.
WO2012173659A3 (en) Lignocellulosic hydrolysates as feedstocks for isobutanol fermentation
WO2013049121A3 (en) Recombinant phage and methods
WO2014022702A3 (en) Methods and compositions for controlling gene expression by rna processing
SG10201810830UA (en) Cell culture compositions and methods for polypeptide production
MX2015005251A (es) Metodos para producir 5-(halometil)furfural.
MX2013007650A (es) Metodo de cultivo de celulas animales.
NZ627373A (en) Genes involved in noscapine production
WO2012103261A3 (en) Compositions and methods for succinate production
MY164858A (en) Microorganisms of corynebacterium which can utilize xylose and method for producing l-lysine using same
NZ719881A (en) Plant cytochrome p450
WO2012096461A3 (ko) 줄기세포의 부유배양용 조성물
MX2019007766A (es) Variantes de enzima con propiedades de ester sintasa mejoradas.
EP2647698A4 (en) PROCESS FOR PRODUCING EOSINOPHILES FROM PLURIPOTENT STEM CELLS
WO2012054935A3 (en) Formation of hematopoietic progenitor cells from mesenchymal stem cells
MX2013009403A (es) Agrupamiento genico para la biosintesis de cicloclavina.
CA2865497A1 (en) Method for guiding the derivation of endothelial cells from human pluripotent stem cells employing two-dimensional, feeder-free differentiation
WO2011086447A3 (en) Fermentation process for the preparation of recombinant heterologous proteins
WO2012150976A3 (en) Methods and compositions for the production of extremophile enzymes from green microalgae and cyanobacteria
HK1198657A1 (en) Addition of iron to improve cell culture